Literature DB >> 21267775

Validation of a self-concept scale for Lynch syndrome in different nationalities.

Helle Vendel Petersen1, Katarina Domanska, Pär-Ola Bendahl, Jiahui Wong, Christina Carlsson, Inge Bernstein, Mary Jane Esplen, Mef Nilbert.   

Abstract

Learning about hereditary cancer may influence an individual's self-concept, which otherwise represents a complex but stable cognitive structure. Recently, a 20-statement self-concept scale, with subscales related to stigma-vulnerability and bowel symptom-related anxiety, was developed for Lynch syndrome. We compared the performance of this scale in 591 mutation carriers from Denmark, Sweden and Canada. Principal component analysis identified two sets of linked statements-the first related to feeling different, isolated and labeled, and the second to concern and worry about bowel changes. The scale performed consistently in the three countries. Minor differences were identified, with guilt about passing on a defective gene and feelings of losing one's privacy being more pronounced among Canadians, whereas Danes more often expressed worries about cancer. Validation of the Lynch syndrome self-concept scale supports its basic structure, identifies dependence between the statements in the subscales and demonstrates its applicability in different Western populations.

Entities:  

Mesh:

Year:  2011        PMID: 21267775     DOI: 10.1007/s10897-011-9349-x

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  27 in total

Review 1.  Psychosocial issues in cancer genetics--current status and future directions.

Authors:  Eveline M A Bleiker; Daniela E E Hahn; Neil K Aaronson
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

2.  Translation of scales in cross-cultural research: issues and techniques.

Authors:  Eun-Seok Cha; Kevin H Kim; Judith A Erlen
Journal:  J Adv Nurs       Date:  2007-04-17       Impact factor: 3.187

3.  Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation.

Authors:  D A Stupart; P A Goldberg; U Algar; R Ramesar
Journal:  Colorectal Dis       Date:  2009-02       Impact factor: 3.788

4.  Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study.

Authors:  K Aktan-Collan; A Haukkala; J P Mecklin; A Uutela; H Kääriäinen
Journal:  Int J Cancer       Date:  2001-08-15       Impact factor: 7.396

5.  Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.

Authors:  Ellen R Gritz; Susan K Peterson; Sally W Vernon; Salma K Marani; Walter F Baile; Beatty G Watts; Christopher I Amos; Marsha L Frazier; Patrick M Lynch
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

Review 6.  Psychological impact of genetic testing for cancer susceptibility: an update of the literature.

Authors:  Bettina Meiser
Journal:  Psychooncology       Date:  2005-12       Impact factor: 3.894

7.  Experiences of genetic risk: disclosure and the gendering of responsibility.

Authors:  L d'Agincourt-Canning
Journal:  Bioethics       Date:  2001-06       Impact factor: 1.898

8.  Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members.

Authors:  M Keller; R Jost; C M Haunstetter; H Sattel; C Schroeter; U Bertsch; F Cremer; P Kienle; M Tariverdian; M Kloor; J Gebert; A Brechtel
Journal:  Clin Genet       Date:  2008-11       Impact factor: 4.438

9.  Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma.

Authors:  Yoshie Murakami; Hitoshi Okamura; Kokichi Sugano; Teruhiko Yoshida; Keiko Kazuma; Tatsuo Akechi; Yosuke Uchitomi
Journal:  Cancer       Date:  2004-07-15       Impact factor: 6.860

10.  The FAP self-concept scale (adult form).

Authors:  Mary Jane Esplen; Noreen Stuckless; Terri Berk; Kate Butler; Steve Gallinger
Journal:  Fam Cancer       Date:  2008-08-13       Impact factor: 2.375

View more
  6 in total

1.  Balancing life with an increased risk of cancer: lived experiences in healthy individuals with Lynch syndrome.

Authors:  Helle Vendel Petersen; Mef Nilbert; Inge Bernstein; Christina Carlsson
Journal:  J Genet Couns       Date:  2014-01-08       Impact factor: 2.537

2.  Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome.

Authors:  M J Esplen; N Stuckless; S Gallinger; M Aronson; H Rothenmund; K Semotiuk; J Stokes; C Way; J Green; K Butler; H V Petersen; J Wong
Journal:  Clin Genet       Date:  2011-10-03       Impact factor: 4.438

3.  Limited impact on self-concept in individuals with Lynch syndrome; results from a national cohort study.

Authors:  Helle Vendel Petersen; Mary Jane Esplen; Steen Ladelund; Inge Bernstein; Lone Sunde; Christina Carlsson; Mef Nilbert
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

Review 4.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

5.  Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.

Authors:  Lisa G Aspinwall; Tammy K Stump; Jennifer M Taber; Danielle M Drummond; Wendy Kohlmann; Marjan Champine; Sancy A Leachman
Journal:  Transl Behav Med       Date:  2018-01-29       Impact factor: 3.046

6.  Sense of coherence and self-concept in Lynch syndrome.

Authors:  Helle Vendel Petersen; Steen Ladelund; Christina Carlsson; Mef Nilbert
Journal:  Hered Cancer Clin Pract       Date:  2013-07-05       Impact factor: 2.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.